Deal focus: Australia’s ENA hits COVID-19 in the nose
Australian investors see hope in ENA Respiratory, a nasal spray specialist aiming to complement global COVID-19 vaccine programs with an immune system-boosting product
Australia’s Brandon Capital, a life sciences VC firm, and Minderoo Foundation, a non-profit that has pivoted much of its activity toward stemming the pandemic, are used to dismissing investment opportunities...
More on Australasia
Latest News
GGV to spin off Asia operation
GGV Capital’s Asia business will sever ties with the firm’s international operation – switching to separate partnerships and a distinct brand – as venture capital continues to feel the impact of the US and China’s conflicting technology agendas.
JIP-led consortium completes Toshiba tender offer
A consortium led by Japan Industrial Partners (JIP) has successfully completed a tender offer for Toshiba Corporation, paving the way for a JPY 2trn (USD 13.6bn) privatisation of the company.
Peak XV, Elevation, Andreessen back India visa platform
Peak XV Partners, formerly Sequoia Capital India, and Elevation Capital have led a USD 12m Series A round for Indian visa platform Atlys with support from Andreessen Horowitz.
Australia's PEP buys stake in biogas business from Sims
Pacific Equity Partners (PEP) has agreed to pay AUD 272.1m (USD 174m) for a 50% stake in LMS Energy, a biogas-to-energy and solar renewable energy business held by Australian metals recycler Sims.